Efficacy and safety of Fingolimod therapy in multi-ethnic Malaysian patients with relapsing remitting multiple sclerosis: A longitudinal observational study

被引：1
作者：
Viswanathan, S. [1 ]
机构：
[1] Kuala Lumpur Hosp, Dept Neurol, Kuala Lumpur, Malaysia
来源：
JOURNAL OF CLINICAL NEUROSCIENCE | 2018年 / 54卷
关键词：
CLINICAL-PRACTICE; ORAL FINGOLIMOD; DOUBLE-BLIND; NATALIZUMAB; FTY720;
D O I：
10.1016/j.jocn.2018.04.062
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：25 / 28
页数：4
相关论文
共 16 条
[1]  
[Anonymous], J NEUROL NEUROSURG P
[2]   Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study [J].
Baldi, Eleonora ;
Guareschi, Angelica ;
Vitetta, Francesca ;
Senesi, Caterina ;
Curti, Erica ;
Montepietra, Sara ;
Simone, Anna Maria ;
Immovilli, Paolo ;
Caniatti, Luisa ;
Tola, Maria Rosaria ;
Pesci, Ilaria ;
Montanari, Enrico ;
Sola, Patrizia ;
Granella, Franco ;
Motti, Luisa ;
Ferraro, Diana .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (09) :1849-1855
[3]   Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort [J].
Braune, Stefan ;
Lang, M. ;
Bergmann, A. .
JOURNAL OF NEUROLOGY, 2013, 260 (12) :2981-2985
[4]   Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial [J].
Calabresi, Peter A. ;
Radue, Ernst-Wilhelm ;
Goodin, Douglas ;
Jeffery, Douglas ;
Rammohan, Kottil W. ;
Reder, Anthony T. ;
Vollmer, Timothy ;
Agius, Mark A. ;
Kappos, Ludwig ;
Stites, Tracy ;
Li, Bingbing ;
Cappiello, Linda ;
von Rosenstiel, Philipp ;
Lublin, Fred D. .
LANCET NEUROLOGY, 2014, 13 (06) :545-556
[5]   Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis [J].
Chun, Jerold ;
Hartung, Hans-Peter .
CLINICAL NEUROPHARMACOLOGY, 2010, 33 (02) :91-101
[6]   Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS [J].
Cohen, Jeffrey A. ;
Barkhof, Frederik ;
Comi, Giancarlo ;
Izquierdo, Guillermo ;
Khatri, Bhupendra ;
Montalban, Xavier ;
Pelletier, Jean ;
Eckert, Benjamin ;
Haering, Dieter A. ;
Francis, Gordon .
JOURNAL OF NEUROLOGY, 2013, 260 (08) :2023-2032
[7]   Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study [J].
Devonshire, Virginia ;
Havrdova, Eva ;
Radue, Ernst Wilhelm ;
O'Connor, Paul ;
Zhang-Auberson, Lixin ;
Agoropoulou, Catherine ;
Haering, Dieter Adrian ;
Francis, Gordon ;
Kappos, Ludwig .
LANCET NEUROLOGY, 2012, 11 (05) :420-428
[8]   Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study [J].
Gajofatto, Alberto ;
Bianchi, Maria Rachele ;
Deotto, Luciano ;
Benedetti, Maria Donata .
EUROPEAN NEUROLOGY, 2014, 72 (3-4) :173-180
[9]   Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod [J].
Hoepner, Robert ;
Havla, Joachim ;
Eienbroeker, Christian ;
Tackenberg, Bjoern ;
Hellwig, Kerstin ;
Meinl, Ingrid ;
Hohlfeld, Reinhard ;
Gold, Ralf ;
Kuempfel, Tania ;
Kleiter, Ingo .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (13) :1714-1720
[10]   Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis [J].
Kalincik, Tomas ;
Horakova, Dana ;
Spelman, Tim ;
Jokubaitis, Vilija ;
Trojano, Maria ;
Lugaresi, Alessandra ;
Izquierdo, Guillermo ;
Rozsa, Csilla ;
Grammond, Pierre ;
Alroughani, Raed ;
Duquette, Pierre ;
Girard, Marc ;
Pucci, Eugenio ;
Lechner-Scott, Jeannette ;
Slee, Mark ;
Fernandez-Bolanos, Ricardo ;
Grand'Maison, Francois ;
Hupperts, Raymond ;
Verheul, Freek ;
Hodgkinson, Suzanne ;
Oreja-Guevara, Celia ;
Spitaleri, Daniele ;
Barnett, Michael ;
Terzi, Murat ;
Bergamaschi, Roberto ;
McCombe, Pamela ;
Sanchez-Menoyo, Jose ;
Simo, Magdolna ;
Csepany, Tunde ;
Rum, Gabor ;
Boz, Cavit ;
Havrdova, Eva ;
Butzkueven, Helmut .
ANNALS OF NEUROLOGY, 2015, 77 (03) :425-435
12